Medicine and Dentistry
Riluzole
100%
Shy-Drager Syndrome
100%
Pooled Analysis
100%
Disease
100%
Progressive Supranuclear Palsy
100%
Blood Pressure
100%
Prevalence
50%
Diastolic Blood Pressure
41%
Placebo
33%
Log Rank Test
16%
Population Growth
16%
Systolic Blood Pressure
16%
Mean Arterial Pressure
16%
Diseases
16%
Drug Effect
16%
Chronic Kidney Disease
8%
Cardiovascular Disease
8%
Kaplan Meier Method
8%
Sensitivity and Specificity
8%
Deterioration
8%
Histopathology
8%
Parkinson Plus Syndrome
8%
Elevated Blood Pressure
8%
Prognostic Factor
8%
Neuroprotection
8%
Disease Exacerbation
8%
Intention-to-Treat Analysis
8%
Treatment Group
8%
Adverse Effect
8%
Depressed Blood Pressure
8%
Neuroscience
Positron Emission Tomography
100%
Multiple System Atrophy
100%
In Vivo
100%
Clinical Intervention
100%
Progressive Supranuclear Palsy
100%
Flumazenil
100%
Riluzole
100%
Placebo
33%
Motor Cortex
20%
Magnetic Resonance Imaging
20%
Synapse
20%
Brain Areas
20%
GABAA Receptor
20%
Benzodiazepine
20%
Histopathology
8%
Adverse Effect
8%
Neuroprotection
8%
Agricultural and Biological Sciences
Riluzole
100%
Blood Pressure
100%
Body Mass Index
100%
Underweight
62%
Placebo
57%
Diastolic Blood Pressure
35%
Endpoints
14%
Natural History
14%
Adverse Effects
14%
Relative Risk
14%
Mean Arterial Pressure
14%
Systolic Blood Pressure
14%
Population Growth
14%
Population Distribution
12%
Cardiovascular System
7%
Risk Factor
7%